Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.38% |
| 2 | Healthcare | 7.46% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.11% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Expedia Group
EXPE
$38.6B
| $48.7M | 0.02% |
445,345
+10,315
| +2% | +$1.01M |
|
|
HES
752
DELISTED
Hess
HES
| $48.7M | 0.02% |
358,215
+190,817
| +114% | +$26.1M |
|
753
CarMax
KMX
$8.82B
| $48.6M | 0.02% |
581,179
+550,921
| +1,821% | +$40.3M |
|
754
PUT
EQT Corp
EQT
$33.6B
| $48.6M | 0.02% |
1,181,400
+1,121,200
| +1,862% | +$39.6M |
|
755
CareTrust REIT
CTRE
$9.35B
| $48.6M | 0.02% |
2,446,287
+1,928,626
| +373% | +$37.7M |
|
756
Takeda Pharmaceutical
TAK
$58.1B
| $48.5M | 0.02% |
3,085,166
-754,816
| -20% | -$12.4M |
|
757
iShares Biotechnology ETF
IBB
$10.7B
| $48.4M | 0.02% |
380,980
+368,681
| +2,998% | +$47.9M |
|
|
SCRM
758
DELISTED
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
| $48.3M | 0.02% |
4,679,620
-62,926
| -1% | -$644K |
|
759
STMicroelectronics
STM
$45.1B
| $48.3M | 0.02% |
965,711
+481,736
| +100% | +$22.3M |
|
760
Timken Company
TKR
$8.67B
| $48.2M | 0.02% |
526,999
-102,564
| -16% | -$8.09M |
|
761
International Flavors & Fragrances
IFF
$21.5B
| $48.2M | 0.02% |
605,430
+215,030
| +55% | +$18.5M |
|
762
United Airlines
UAL
$36.7B
| $48M | 0.02% |
875,326
-192,985
| -18% | -$9.11M |
|
763
Enphase Energy
ENPH
$5.1B
| $48M | 0.02% |
286,620
-299,548
| -51% | -$53.5M |
|
764
Enbridge
ENB
$110B
| $47.8M | 0.02% |
1,286,089
+560,554
| +77% | +$21.4M |
|
765
CALL
Charter Communications
CHTR
$17.9B
| $47.7M | 0.02% |
129,800
-8,200
| -6% | -$2.8M |
|
|
NARI
766
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $47.6M | 0.02% |
818,327
+406,786
| +99% | +$25.7M |
|
767
PUT
Starbucks
SBUX
$122B
| $47.3M | 0.02% |
477,900
+150,700
| +46% | +$15.6M |
|
768
SEI Investments
SEIC
$13.1B
| $47.3M | 0.02% |
793,591
+748,780
| +1,671% | +$43.6M |
|
769
CALL
Elevance Health
ELV
$86.9B
| $47.3M | 0.02% |
106,400
-30,900
| -23% | -$14.3M |
|
|
DO
770
DELISTED
Diamond Offshore Drilling, Inc.
DO
| $47.3M | 0.02% |
3,318,142
+801,347
| +32% | +$9.49M |
|
771
Steel Dynamics
STLD
$32.8B
| $47.2M | 0.02% |
433,552
+374,866
| +639% | +$38.1M |
|
772
PUT
iShares MSCI Emerging Markets ETF
EEM
$31.2B
| $47.2M | 0.02% |
1,193,800
-1,480,700
| -55% | -$58.2M |
|
773
McCormick & Company Non-Voting
MKC
$14.9B
| $47.2M | 0.02% |
541,012
-30,009
| -5% | -$2.65M |
|
774
Transocean
RIG
$6.61B
| $47M | 0.02% |
6,710,437
+6,017,699
| +869% | +$37.2M |
|
775
American Tower
AMT
$81.9B
| $46.9M | 0.02% |
241,882
+72,705
| +43% | +$14.2M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander deployed $14B of net new capital in Q2 2023, opening 870 new positions and adding to 2,213 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.